alanylglutamine has been researched along with zearalenone in 1 studies
| Studies (alanylglutamine) | Trials (alanylglutamine) | Recent Studies (post-2010) (alanylglutamine) | Studies (zearalenone) | Trials (zearalenone) | Recent Studies (post-2010) (zearalenone) |
|---|---|---|---|---|---|
| 271 | 73 | 112 | 2,356 | 41 | 1,352 |
| Protein | Taxonomy | alanylglutamine (IC50) | zearalenone (IC50) |
|---|---|---|---|
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 2.402 | |
| PTK2B protein tyrosine kinase 2 beta | Homo sapiens (human) | 6.922 | |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 2.402 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, A; Li, J; Shan, A; Wang, J; Yang, L | 1 |
1 other study(ies) available for alanylglutamine and zearalenone
| Article | Year |
|---|---|
Protective effect of glutamine and alanyl-glutamine against zearalenone-induced intestinal epithelial barrier dysfunction in IPEC-J2 cells.
Topics: Animals; Apoptosis; Cell Line; Dipeptides; Epithelial Cells; Estrogens, Non-Steroidal; Glutamine; Intestinal Diseases; Intestinal Mucosa; Intestines; Permeability; Protective Agents; Reactive Oxygen Species; Zearalenone | 2021 |